Fierce Pharma Week 2025

About

In this insightful session at Fierce Pharma, discover practical strategies empowering Medical Science Liaisons (MSLs) to engage Key Opinion Leaders (KOLs) more effectively. This session delves into bridging the gap between access and meaningful impact, equipping MSLs with the tools and confidence to build credible, relevant scientific relationships that drive positive outcomes in pharmaceutical engagement. Watch the full video to learn how ProcDNA is revolutionizing MSL KOL interactions for greater impact and relevance.

Download

Speakers

Harpreet Singh

Co-founder, ProcDNA

Bryan Goldberg

Sr. Director, Strategy & Ops, Pharmacosmos

Key Takeaways for the Audience

From Access to Impact

Shifting MSL engagement from merely accessing KOLs to creating meaningful, impactful scientific relationships that drive real world outcomes.

Building MSL Confidence and Credibility

Equipping MSLs with skills and strategies to engage KOLs confidently and establish themselves as trusted scientific partners.

Strategic KOL Prioritization

Identifying and focusing on KOLs who align closely with therapeutic goals and organizational priorities to maximize engagement relevance.

Data-Driven Personalization

Leveraging insights and digital tools to tailor interactions that resonate with individual KOLs’ interests and scientific priorities.

Trust through Transparent Dialogue

Establishing trust by maintaining transparent, evidence based, and ethically sound scientific communication with KOLs.

Measuring Engagement Success

Tracking engagement effectiveness by going beyond interaction counts to assess influence on decision making and outcomes.

Gain insights from our latest webinars

Want to Join our Next Webinar? Get in Touch with us

Stay informed with expert-led insights, practical case discussions, and the latest industry trends. Connect with us to reserve your place in our upcoming webinar.